3D-QSAR of Novel Phosphodiesterase-4 Inhibitors by Genetic Function Approximation

By  

Medicinal Chemistry, Vol. 7, Iss. 6, 2011-11 ,pp. : 543-552

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors and the Treatment of Asthma: Where Are We Now and Where Do We Go from Here?

By Giembycz M.A.  

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 193-212

Adis International

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M.   Gristwood R.W.   Cooper N.   Hellewell P.G.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Nicotinamide derivatives as selective inhibitors of PDE4

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 481-485

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy

By Movsesian Matthew A   Alharethi Rami  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite